EP0717992A2 — Aqueous suspension formulations for pharmaceutical applications
Assigned to Kenvue Brands LLC · Expires 1996-06-26 · 30y expired
What this patent protects
The invention features an aqueous pharmaceutical suspension and methods of making same. The suspension comprises a therapeutic amount of controlled release acetaminophen powder, the powder being suspended in a suspending system comprising a suspension stabilizing effective amount…
USPTO Abstract
The invention features an aqueous pharmaceutical suspension and methods of making same. The suspension comprises a therapeutic amount of controlled release acetaminophen powder, the powder being suspended in a suspending system comprising a suspension stabilizing effective amount of xanthan gum, hydroxyethyl cellulose and pregelatinized starch, an effective amount of taste masking composition, and water.
Drugs covered by this patent
- Solosec (SECNIDAZOLE) · Evofem Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.